MARJORIE JOHNSON: Open Payments
NPI 1780854505 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$739 in 28 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $442 · 2025 $739
Food & beverage: $739
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $176 |
| Lilly USA, LLC | 5 | $148 |
| SCPHARMACEUTICALS INC. | 1 | $116 |
| Amgen Inc. | 1 | $116 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $61 |
| Corium, LLC | 2 | $47 |
| PFIZER INC. | 2 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: LEQVIO, FUROSCIX, REPATHA, LifeVest, Azstarys, VYNDAQEL, Kerendia, JARDIANCE.
Industry payments across AL — which companies pay providers there.
